|Last Update: 05/17/13 - 4:00 PM EDT|
|YTD Performance: 18.55%|
|Previous Close: $18.02|
|52 Week Range: $12.04 - $18.20|
|Oustanding Shares: 874,644,725|
|Market Cap: 15,761,097,945|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||19||18||20||19|
|Growth Rate (Year over Year)||23.54%||8.55%||4.64%||-0.40%|
Nothing refreshes like a look at the charts.
FITB was upgraded from Market Perform to Outperform, Wells Fargo said. Company should see improving returns and deliver greater capital flexibility.
FITB estimates were raised through 2014, Credit Suisse said. Leveraged finance is adding to overall loan growth. Outperform rating and new $17 price target.
FITB was upgraded to Outperform, Keefe, Bruyette & Woods said. New analyst has an $18 price target. Company can outperform its peers in the coming quarters.
Shares of FITB now seen reaching $15, according to Bernstein. Estimates also reduced, as the company is realizing higher costs. Market Perform rating.
FITB was downgraded from Buy to Neutral, Compass Point said. $16 price target. Company will struggle to grow revenue in a low interest rate environment.
FITB was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $16.50 price target. Valuation call, as the stock is up 19% since the summer.
FITB was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.
FITB was downgraded from Outperform to Market Perform, Keefe, Bruyette & Woods said. Valuation call, based on a $17 price target.
I can see where people would fade any all-out market strength.